Study to Assess Adverse Events and the Movement of Oral Venetoclax Tablet Through the Body of Female Participants Aged 18-75 Years With Impaired Renal Function
Clinical trial NCT04810598 · COMPLETED
Trial details
- NCT number
- NCT04810598
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-08
- Primary completion
- 2022-08-16
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.